Rapport Therapeutics, Inc. RAPP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$19.86M+41.2% | -$33.76M-25.4% | -$26.93M-0.7% | -$26.73M-11.1% | -$24.06M-20.4% | ||
| $227K-14.3% | $265K+3.5% | $256K+1.6% | $252K+3.3% | $244K-6.2% | ||
| $6.96M+22.4% | $5.69M+20.2% | $4.74M+7.9% | $4.39M+8.6% | $4.04M+25.9% | ||
| -$13.06M+47.1% | -$24.7M-41.4% | -$17.47M+30.3% | -$25.07M-23.9% | -$20.24M-40.1% | ||
| $86K-49.1% | $169K+26.1% | $134K+509% | $22K-92.4% | $291K+28.8% | ||
| $37.94M+122% | -$174.32M-207% | -$56.78M-351% | $22.6M+7.4% | $21.03M— | ||
| $531K+70.7% | $311K-99.9% | $270.53M+429,517% | -$63K-1,360% | $5K-28.6% | ||
| $25.41M+113% | -$198.71M-201% | $196.29M+7,837% | -$2.54M-418% | $799K— | ||
| -$13.15M+47.1% | -$24.87M-41.3% | -$17.6M+29.9% | -$25.09M-22.2% | -$20.53M-39.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rapport Therapeutics, Inc. generate?
- Rapport Therapeutics, Inc. (RAPP) generated -$80.3M in operating cash flow over the trailing twelve months.
- What is Rapport Therapeutics, Inc.'s free cash flow?
- After $411.0K of capital expenditures, Rapport Therapeutics, Inc.'s free cash flow was -$80.7M over the trailing twelve months, down 16.8% year over year.
- Where does Rapport Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.